Investigational Drug Information for ASP0456
✉ Email this page to a colleague
What is the drug development status for ASP0456?
ASP0456 is an investigational drug.
There have been 6 clinical trials for ASP0456.
The most recent clinical trial was a Phase 3 trial, which was initiated on June 24th 2016.
The most common disease conditions in clinical trials are Constipation, Syndrome, and Irritable Bowel Syndrome. The leading clinical trial sponsors are Astellas Pharma Inc and [disabled in preview].
There are one hundred and thirteen US patents protecting this investigational drug and one international patent.
Summary for ASP0456
| US Patents | 113 |
| International Patents | 1,277 |
| US Patent Applications | 357 |
| WIPO Patent Applications | 370 |
| Japanese Patent Applications | 177 |
| Clinical Trial Progress | Phase 3 (2016-06-24) |
| Vendors | 20 |
Recent Clinical Trials for ASP0456
| Title | Sponsor | Phase |
|---|---|---|
| A Study of Oral Dosing of ASP0456 in Patients With Chronic Constipation | Astellas Pharma Inc | Phase 3 |
| A Study to Evaluate Dose Responses of Efficacy and Safety of ASP0456 in Patient With Chronic Constipation | Astellas Pharma Inc | Phase 2 |
| Phase III Study to Evaluate the Efficacy and Safety of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome | Astellas Pharma Inc | Phase 3 |
Clinical Trial Summary for ASP0456
Top disease conditions for ASP0456
Top clinical trial sponsors for ASP0456
US Patents for ASP0456
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| ASP0456 | ⤷ Try a Trial | Fusion polypeptides comprising an active protein linked to a mucin-domain polypeptide | Alkermes, Inc. (Waltham, MA) | ⤷ Try a Trial |
| ASP0456 | ⤷ Try a Trial | Formulations of guanylate cyclase C agonists and methods of use | SYNERGY PHARMACEUTICALS, INC. (New York, NY) | ⤷ Try a Trial |
| ASP0456 | ⤷ Try a Trial | Benzazole compounds and methods for making and using the compounds | Rigel Pharmaceuticals, Inc. (South San Francisco, CA) | ⤷ Try a Trial |
| ASP0456 | ⤷ Try a Trial | Method for treating constipation | GELESIS LLC (Boston, MA) | ⤷ Try a Trial |
| ASP0456 | ⤷ Try a Trial | Fusion partners for peptide production | PFENEX INC. (San Diego, CA) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for ASP0456
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| ASP0456 | Australia | AU2013271541 | 2032-06-08 | ⤷ Try a Trial |
| ASP0456 | Australia | AU2013271542 | 2032-06-08 | ⤷ Try a Trial |
| ASP0456 | Australia | AU2013271545 | 2032-06-08 | ⤷ Try a Trial |
| ASP0456 | Australia | AU2015268652 | 2032-06-08 | ⤷ Try a Trial |
| ASP0456 | Australia | AU2018200597 | 2032-06-08 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
